Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Improving Schools
Improving Schools is a peer reviewed journal for all those engaged in school development, whether improving schools in difficulty or making successful schools even better. The journal includes contributions from across the world with an international readership including teachers, heads, academics, education authority staff, inspectors and consultants.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena maksutta SAGEn hybridilehdissä ja 27:ssa Full OA -lehdessä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating insitutions to publish their articles open access free of charge in Sage hybrid journals and in 27 Full OA journals. The number of articles is unlimited. OA publishing without extra charge applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Impulse: The Premier Undergraduate Neuroscience Journal
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Impulso Revista de Administración
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Analysis
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
In Medias Res
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Medias Res
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Practice
In Practice provides continuing educational material for veterinary practitioners. Peer-reviewed review articles by experts in their field cover all species, but principally farm and companion animals, providing a regular update on clinical developments. Published 10 times a year, it also includes articles on veterinary practice management. First published in 1979, it now provides an extensive archive of clinical review articles. In Practice is produced in conjunction with Veterinary Record, the official journal of the British Veterinary Association (BVA). It is published on behalf of the BVA by BMJ Group.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
In Silico Biology: Journal of Biological Systems Modeling and Multi-Scale Simulation
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena 20% alennuksella APC-maksuista SAGEn avoimissa gold OA-lehdissä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating institutions to publish their articles open access with 20% discount of the journal’s APC (Article Processing Charge) in Sage gold open access journals. The number of articles is unlimited. OA publishing with discount applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/In Silico Pharmacology
genetics, drug-design, behavioral effects, biophysics, biochemistry
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
In Silico Research in Biomedicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Situ : Revue de Patrimoines
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Situ Archaeologica
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Vestigium Ire
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In Vitro Cellular & Developmental Biology - Animal
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
In Vitro Cellular & Developmental Biology - Plant
Founded in 1965, In Vitro Cellular & Developmental Biology - Plant is the only journal devoted solely to worldwide coverage of in vitro biology in plants. Its high-caliber original research and reviews make it required reading for anyone who needs comprehensive coverage of the latest developments and state-of-the-art research in plant cell and tissue culture and biotechnology from around the world. Each year, four issues cover cellular, molecular and developmental biology research using in vitro grown or maintained organs, tissues or cells derived from plants. Two special IAPB issues focus on plant tissue culture, and molecular and cellular aspects of plant biotechnology. The IAPB and SIVB maintain separate, independent editorial review boards for their issues. Coverage extends to a range of topics, including Biotechnology/genetic transformation; Developmental biology/ morphogenesis; Micropropagation; Functional genomics; Molecular farming; Metabolic engineering, and more.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
In Vivo
The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer. The IIAR will advance, protect and support throughout the world the ideals of freedom, peace, health, scientific knowledge, equality, welfare and mutual respect among communities in science and life.This site provides information on the aims and activities of the IIAR, including current cancer research projects and invitations for cooperation.The IIAR is supported by the three international peer-reviewed journals ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS which are also available online through the Stanford University HighWire Press.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In die Skriflig, In Luce Verbi
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In the Library with the Lead Pipe
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
In vitro models
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
In-Scription: revue en ligne d'études épigraphiques
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.